54gene secures $15m Series A funding

On April 14, 54gene completed a series A funding run that raised $15 million courtesy of Adjuvant Capital, which is a fund targeting life sciences ventures and derives its funding from the International Finance Corporation, Bill & Melinda Gates Foundation, and Novartis. Other notable investment…